foxo4-dri senolytic human trial The disordered p53 transactivation domain is the target of FOXO4 and the compound FOXO4-DRI - Averix Labs
Pay in 4 interest-free payments of $6.93 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Jul 27 - Aug 1

00300-7/asset/fc51add5-22b1-4645-9507-e89d0738c67a/main.assets/gr1_lrg.jpg)


